Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

Adagene Collaborates with NIH Lab to Develop Novel CAR-T Candidate
Apic Bio of Massachusetts Raises $40 Million in Series A, Led by Morningside
Legend/Janssen CAR-T Therapy Posts Strong Results in Multiple Myeloma Trial
Elpiscience of Shanghai Raises $35 Million to Develop Immunotherapies
Immunochina Collaborates with Sartorius Stedim for CAR-T Production
Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China